SCHEMBL4199295

SCHEMBL4199295

CS(=O)(=O)N1CCC(NC(=O)O)CC1.O=C(Nc1cn[nH]c1)c1c(Cl)cccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK14 O94921 14/20 0.47
▸ CCNY Q8ND76 12/20 0.47
▸ LMNA P02545 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MAPT P10636 1/20 0.42
▸ CDK2 P24941 2/20 0.41
▸ CCNA1 P78396 2/20 0.41
▸ CASK O14936 1/20 0.41
▸ CCNT1 O60563 1/20 0.41
▸ CDKL5 O76039 1/20 0.41
▸ CCNB2 O95067 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ MAK P20794 1/20 0.41
▸ CDK11B P21127 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CCND3 P30281 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2029686 0.77 CDK14 (0.48) CDK14CCNYLMNARAB9ACDK2
SCHEMBL17252164 0.77 CDK14 (0.70) CDK14CCNYCDK2CCNA1CASK
SCHEMBL4440869 0.77 TYK2 (0.58) MAPK7KMT2A
SCHEMBL13993660 0.75 LMNA (0.46) CDK14CCNYLMNARAB9ACDK2
SCHEMBL29164525 0.74 TYK2 (0.63) RAB9AMAPK7
SCHEMBL8262596 0.72 CDK14 (0.43) CDK14CCNYLMNARAB9ACDK2
SCHEMBL8261492 0.72 CDK2 (0.49) CDK14CCNYLMNARAB9AMAPT
SCHEMBL4936632 0.72 CDK14 (0.46) CDK14CCNYLMNARAB9ACDK2
SCHEMBL8263999 0.71 CDK14 (0.52) CDK14CCNYLMNARAB9ACDK2
SCHEMBL8261512 0.70 CDK14 (0.44) CDK14CCNYLMNARAB9ACCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027109-A1 4- (2, 6-DICHLORO-BENZOYLAMINO) -1H-PYRAZOLE-S-CARBOXYLIC ACID (1-METHANESULPH0NYL-PIPERIDIN-4-YL) -AMIDE FOR THE TREATMENT OF CANCER Astex Therapeutics Limited (GB) 2009-02-25 — — EP disclosed
Send feedback